New Delhi, May 4 -- Pune-based Serum Institute of India (SII), the manufacturer of Covishield, finds itself potentially entangled in legal troubles as the parents of a 21-year-old woman, who allegedly died ten days after receiving the vaccine in 2021, are contemplating suing both the company and UK-based AstraZeneca, the developer of the jab.
The British pharmaceutical giant is already under legal scrutiny in the UK, facing claims in at least 51 cases alleging that its vaccine caused deaths and severe injuries. AstraZeneca recently admitted that its vaccine can, in very rare cases, lead to Thrombosis with Thrombocytopenia Syndrome (TTS).Covishield, derived from the AstraZeneca COVID-19 vaccine, was extensively administered in India. Howeve...